ASHLEA LACEY: Open Payments
NPI 1194563957 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 58 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $132 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $377 |
| ABBVIE INC. | 20 | $203 |
| PFIZER INC. | 4 | $73 |
| Lilly USA, LLC | 4 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Exact Sciences Corporation | 3 | $50 |
| Novo Nordisk Inc | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: BREZTRI, VRAYLAR, AIRSUPRA, TRINTELLIX, Cologuard Collection Kit, Ozempic, UBRELVY, Auvelity.
Industry payments across MO — which companies pay providers there.
